60 DEGREES PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-4.2M | $430.5K | $-2.0M | $4.2M | $-3.3M | $-2.6M |
| Depreciation & Amortization | $1.5K | $407 | — | — | — | — |
| Depreciation | $1.5K | $407 | $1.9K | $5.5K | $6.9K | $6.9K |
| Amortization | $9.5K | $8.2K | — | $7.4K | $6.0K | — |
| Stock-Based Compensation | — | — | $-336.1K | $271.1K | $65.0K | $212.6K |
| Net Cash from Operating Activities | $-1.2M | $-1.1M | $-63.7K | $-3.8M | $-313.5K | $-412.7K |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-130.6K | $-9.8K | $-66.6K | $-27.9K | $-18.1K | $-3.3K |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-865 | $1.9M | $0 | $6.0M | $321.1K | $182.4K |
| Net Change in Cash | $-1.3M | $752.2K | $-76.1K | $2.2M | $-10.9K | $-234.9K |
| Free Cash Flow | — | — | — | — | — | — |